Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Indeed, the increased thrombotic risk caused by hyperhomocysteinemia, recently reviewed by D'Angelo and Selhub (1997), seems to be independent of the conventional risk factors including protein C, protein S, and antithrombin III deficiencies
Some patients abandon therapy after reaching their target weight, while others are forced to pause or switch treatments due to supply shortages
0.2 to 1.5 mg - from $399 1.9 to 2.3 mg - from $499 Ideal for patients at a higher non-starter dose or wanting to titrate up to a higher therapeutic dose
If medicine can give people the help they need, alongside diet and exercise, it could improve not only health but also how we view those living with obesity.
